Hypoxia as a driver of resistance to immunotherapy
J Kopecka, IC Salaroglio, E Perez-Ruiz… - Drug Resistance …, 2021 - Elsevier
Hypoxia, a hallmark of solid tumors, determines the selection of invasive and aggressive
malignant clones displaying resistance to radiotherapy, conventional chemotherapy or …
malignant clones displaying resistance to radiotherapy, conventional chemotherapy or …
Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets
J Kopecka, P Trouillas, AČ Gašparović, E Gazzano… - Drug resistance …, 2020 - Elsevier
Lipids, phospholipids and cholesterol in particular, are the predominant components of the
plasma membrane, wherein multidrug efflux transporters of the ATP-binding cassette (ABC) …
plasma membrane, wherein multidrug efflux transporters of the ATP-binding cassette (ABC) …
[HTML][HTML] The untapped potential of ascites in ovarian cancer research and treatment
The build-up of fluid in the peritoneal cavity—ascites—is a hallmark of ovarian cancer, the
most lethal of all gynaecological malignancies. This remarkable fluid, which contains a …
most lethal of all gynaecological malignancies. This remarkable fluid, which contains a …
[HTML][HTML] Influence of cholesterol on cancer progression and therapy
SS Mayengbam, A Singh, AD Pillai, MK Bhat - Translational oncology, 2021 - Elsevier
Cholesterol is a fundamental molecule necessary for the maintenance of cell structure and is
vital to various normal biological functions. It is a key factor in lifestyle-related diseases …
vital to various normal biological functions. It is a key factor in lifestyle-related diseases …
Impact of cancer metabolism on therapy resistance–clinical implications
AC Gonçalves, E Richiardone, J Jorge, B Polónia… - Drug Resistance …, 2021 - Elsevier
Despite an increasing arsenal of anticancer therapies, many patients continue to have poor
outcomes due to the therapeutic failures and tumor relapses. Indeed, the clinical efficacy of …
outcomes due to the therapeutic failures and tumor relapses. Indeed, the clinical efficacy of …
Dysregulation of cholesterol metabolism in cancer progression
X Liu, M Lv, W Zhang, Q Zhan - Oncogene, 2023 - nature.com
Cholesterol homeostasis has been implicated in the regulation of cellular and body
metabolism. Hence, deregulated cholesterol homeostasis leads to the development of many …
metabolism. Hence, deregulated cholesterol homeostasis leads to the development of many …
[HTML][HTML] Involvement of LDL and ox-LDL in cancer development and its therapeutical potential
CF Deng, N Zhu, TJ Zhao, HF Li, J Gu, DF Liao… - Frontiers in …, 2022 - frontiersin.org
Lipid metabolism disorder is related to an increased risk of tumorigenesis and is involved in
the rapid growth of cancer cells as well as the formation of metastatic lesions …
the rapid growth of cancer cells as well as the formation of metastatic lesions …
LDL, HDL and endocrine-related cancer: From pathogenic mechanisms to therapies
Cholesterol is essential for a variety of functions in endocrine-related cells, including
hormone and steroid production. We have reviewed the progress to date in research on the …
hormone and steroid production. We have reviewed the progress to date in research on the …
[HTML][HTML] Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review
M Kanmalar, SF Abdul Sani, NINB Kamri… - Cellular & molecular …, 2022 - Springer
Bladder cancer is the fourth most common malignancy in males. It can present across the
whole continuum of severity, from mild through well-differentiated disease to extremely …
whole continuum of severity, from mild through well-differentiated disease to extremely …
[HTML][HTML] Emerging insights into liver X receptor α in the tumorigenesis and therapeutics of human cancers
N Han, M Yuan, L Yan, H Tang - Biomolecules, 2023 - mdpi.com
Liver X receptor α (LXRα), a member of the nuclear receptor superfamily, is identified as a
protein activated by ligands that interacts with the promoters of specific genes. It regulates …
protein activated by ligands that interacts with the promoters of specific genes. It regulates …